Newborn Screening Center - NIH

Screening for inherited metabolic and genetic disorders to prevent mental
retardation and death.       
                                                                            Newborn Screening Laboratory

Established in 1997, the Newborn Screening Center—NIH is the first Department of Health (DOH) accredited Newborn Screening Facility in the country providing the most advanced newborn screening test that can now screen for more than twenty disorders with Expanded Newborn Screening.

Expanded Newborn Screening allows the detection of more genetic disorders which includes the following:

  • Glucose-6 Phosphate Dehydrogenase Deficiency
  • Congenital Hypothyroidism
  • Congenital Adrenal Hyperplasia
  • Galactosemia
  • Phenylketonuria
  • Maple Syrup Urine Disease
  • Cystic Fibrosis
  • Biotinidase Deficiency
  • Organic Acid Disorders
  • Fatty Acid Oxidation Disorders
  • Amino Acid Disorders
  • Urea Cycle Disorders
  • Hemoglobin Disorders

*Read more on the additional disorders detected through expanded newborn screening by downloading the Fact Sheets for Doctors here and for parents here

FREQUENTLY ASKED QUESTIONS (FAQs):

 
 
The expanded newborn screening program will increase the screening panel of disorders from six (6) to twenty-eight (28). This will provide opportunities to significantly improve the quality of life of affected newborns through facilitating early diagnosis and early treatment.

 

Why is it important to have expanded newborn screening?Most babies with metabolic disorders look "normal" at birth. By doing NBS, metabolic disorders may be detected even before clinical signs and symptoms are present. And as a result of this, treatment can be given early to prevent consequences of un-treated conditions.

What is the difference between newborn screening and expanded newborn screening?The difference is the number of disorders each of them can detect. Both tests are performed by collecting a few drops of blood through the heel-prick method but the laboratory testing methods applied are different.

What are the additional disorders tested by expanded newborn screening?Aside from the six conditions in the present panel Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, Galactosemia, Phenylketonuria, Maple Syrup Urine Disease and Glucose-6-Phosphate Dehydrogenase deficiency --expanded newborn screen-ing will screen for additional disorders falling under various groups of conditions namely: hemoglobinopathies, disorders of amino acid and organic acid metabolism, disorders of fatty acid oxidation, disorders of carbohydrate metabolism, disorders of biotin metabolism and cystic fibrosis.

Expanded newborn screening will be offered to you as an option in all newborn screening facilities. The first option is screening for the six disorders at ₱550, which is included in the newborn care package for Philhealth members and the second option is screening for the full complement of 28 disorders at ₱1500.
 
Currently, only P550 is covered by Philhealth. If you are a Philhealth member, and opt to have your baby undergo expanded newborn screening, you will pay the remaining cost which is P950.
 
A positive newborn screen does not mean that your baby has the disorder. Newborn screening simply screens for babies who are more likely to have one of these disorders. The presence of an abnormal screening test result warrants additional tests and/ or a referral to a specialist to confirm whether or not your baby really has the disorder.
 
Newborn screening is ideally done immediately after 24 hours from birth.
 
A few drops of blood are taken from the baby's heel, blotted on a special absorbent filter card and then sent to Newborn Screening Center (NSC).
 
The blood sample for NBS may be collected by any of the following: physician, nurse, medical technologist or trained midwife.
 
Newborn screening is available in Hospitals, Lying-ins, Rural Health Unit, Health Centers and some private clincs. If babies are delivered at home, babies may be brought to the nearest institution offering newborn screening.
 
Results can be claimed from the health facility where NBS was availed. Normal NBS Results are available by 7 - 14 working days from the time samples are received at the NSC.

 

Positive NBS results are relayed to the parents immediately by the health facility. Please ensure that the address and phone number you will provide to the health facility are correct.

A NEGATIVE SCREEN MEANS THAT THE NBS RESULT IS NORMAL.

A positive screen means that the newborn must be brought back to his/her health practitioner for further testing.

 

Contact the NEWBORN SCREENING CENTER—NIH for more information:
Newborn Screening Center—National Institutes of Health
Rm 102, Building H, UP Ayala Land TechnoHub Complex
Commonwealth Avenue, Diliman, Quezon City, 1101 Philippines
Tel Nos. (632)3760962, 3760964, 3760965, 3760967
Fax No. (632) 9216395
Facebook: Newborn Screening Center—NIH
Twitter: @nsc-nih